Trials / Conditions / Neuroendocrine Carcinomas (NEC)
Neuroendocrine Carcinomas (NEC)
5 registered clinical trials studyying Neuroendocrine Carcinomas (NEC) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma NCT07156019 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783 | Inkeun Park | Phase 2 |
| Not Yet Recruiting | A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma NCT07014540 | Beijing GoBroad Hospital | Phase 4 |
| Recruiting | A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) NCT05652686 | Phanes Therapeutics | Phase 1 / Phase 2 |
| Unknown | A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumou NCT04525638 | Fundación de investigación HM | Phase 2 |